Characterization of Foveal Development in Treatment-Naïve Extremely Preterm Infants.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
01 06 2022
Historique:
entrez: 13 6 2022
pubmed: 14 6 2022
medline: 16 6 2022
Statut: ppublish

Résumé

To characterize and quantify foveal development in treatment-naïve extremely preterm infants using optical coherence tomography. In this cross-sectional study, eyes treated for retinopathy of prematurity before imaging were excluded. Inner retinal thickness and outer retina thickness at foveal center and foveal rim were assessed. Extremely preterm (EPT, <28 weeks gestational age) eyes were compared with infants more than 28 weeks of gestation using a multivariable dimension reduction analysis (principal component analysis) and a bilinear factor mode analysis (partial least square discriminant analysis) to determine group intervariability. Further analyses were performed to investigate the effects of gestation on foveal development. Twenty-six infants born at gestational ages ranging from 22 to 39 weeks were imaged between 32 and 80 weeks postmenstrual age. A principal component analysis and partial least squares discriminant analysis revealed that the foveal inner retina thickness was the main difference between EPT infants and non-EPT infants. This difference was reflected by comparing their inner retinal thickness over time (32-80 weeks postmenstrual age), which revealed a sustained thicker foveal inner retina for EPT infants when compared with non-EPT infants. The foveal pit seemed to be shallower in EPT infants when compared with non-EPT infants. Twenty-eight weeks of gestation seems to be a critical timepoint for foveal development; EPT infants had altered foveal inner retinal development throughout early postnatal development, which led to a thicker foveal inner retina and a shallower foveal pit soon after birth. Measuring untreated foveal parameters informs about the effects of prematurity on the fovea and provides a baseline when comparing with post-treatment foveal development.

Identifiants

pubmed: 35696134
pii: 2782972
doi: 10.1167/tvst.11.6.11
pmc: PMC9202331
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Références

Arch Ophthalmol. 2005 Jul;123(7):991-9
pubmed: 16009843
Lancet Glob Health. 2019 Aug;7(8):e1130-e1138
pubmed: 31303299
Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):23
pubmed: 34269816
Prog Retin Eye Res. 2018 Sep;66:49-84
pubmed: 29609042
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):4948-4958
pubmed: 28973368
Vision Res. 1986;26(6):847-55
pubmed: 3750868
Retina. 2020 Aug;40(8):1592-1602
pubmed: 31356497
Invest Ophthalmol Vis Sci. 2015 Jan 13;56(2):908-13
pubmed: 25587063
Am J Ophthalmol Case Rep. 2020 Feb 24;18:100624
pubmed: 32154434
Eye (Lond). 2019 Dec;33(12):1890-1896
pubmed: 31273311
Anesth Analg. 2015 Jun;120(6):1337-51
pubmed: 25988638
Retina. 2020 Jul;40(7):1344-1352
pubmed: 31157715
BMC Genomics. 2006 Jun 08;7:142
pubmed: 16762068
Int J Gynaecol Obstet. 2020 Jul;150(1):31-33
pubmed: 32524596
Lancet. 2013 Oct 26;382(9902):1445-57
pubmed: 23782686
Ophthalmol Retina. 2021 Jun;5(6):580-592
pubmed: 32927150
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):25
pubmed: 33599735
Am J Ophthalmol. 2012 Nov;154(5):779-789.e2
pubmed: 22898189
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):28
pubmed: 32936301
Am J Ophthalmol. 2020 Nov;219:177-185
pubmed: 32569738
Ophthalmology. 1984 Jun;91(6):603-12
pubmed: 6462623
Am J Ophthalmol. 2012 Nov;154(5):767-778.e2
pubmed: 22935600
Retina. 2019 Nov;39(11):2233-2239
pubmed: 30180146
Ophthalmology. 2011 Dec;118(12):2315-25
pubmed: 21940051
Ophthalmology. 2019 Jan;126(1):107-112
pubmed: 30092239
Eye (Lond). 2020 Jun;34(6):1077-1085
pubmed: 31645674
Ophthalmology. 2018 Mar;125(3):444-452
pubmed: 29103792
Bioinformatics. 2002;18 Suppl 1:S105-10
pubmed: 12169537

Auteurs

Ye He (Y)

Department of Ophthalmology, Doheny Eye Institute, Stein Eye institute, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.

Moritz Pettenkofer (M)

Department of Ophthalmology, Doheny Eye Institute, Stein Eye institute, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.

Alison Chu (A)

Department of Pediatrics, Division of Neonatology and Developmental Biology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.

Srinivas R Sadda (SR)

Department of Ophthalmology, Doheny Eye Institute, Stein Eye institute, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.

Giulia Corradetti (G)

Department of Ophthalmology, Doheny Eye Institute, Stein Eye institute, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.

Irena Tsui (I)

Department of Ophthalmology, Doheny Eye Institute, Stein Eye institute, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH